ClinicalTrials.gov
ClinicalTrials.gov Menu

Italian Platelet Technology Assessment Study (IPTAS)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01642563
Recruitment Status : Terminated (Patient enrolment below planned schedule)
First Posted : July 17, 2012
Last Update Posted : July 28, 2015
Sponsor:
Collaborators:
Cerus Corporation
Terumo BCT
Information provided by (Responsible Party):
Centro Nazionale Sangue

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Actual Primary Completion Date : October 2014
  Actual Study Completion Date : March 2015
Publications:
Rebulla P, Grazzini G, Liumbruno GM, Aprili G, Formisano S, Girelli G, Marconi M, Salvaneschi L, Strada P, Zolla L. Pathogen inactivated platelets and prevention of immunological adverse reactions: the Italian Platelet Technology Assessment Study (IPTAS). Blood Transfus 2009;7 Suppl 1:s19-s21. DOI 10.2450/2009.0013-09.